BR1019

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameBR1019
Drug Alias NameBR1019BR-1019
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes MellitusEssential Hypertension +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoryung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoryung Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes MellitusEssential Hypertension +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A